In his first State of the Union speech, President Trump once again promised to lower the swelling costs of prescription drugs. The question is – will the administration do it without imposing price controls.

The House and Senate are in session this week.

Last month, the Consumer Financial Protection Bureau (CFPB) announced a new proposed rule designed to line the pockets of trial lawyers. The seemingly innocuous rule would effectively outlaw certain contractual provisions related to consumer financial products. But rather than protecting consumers, this proposed rule was about helping trial lawyers, a special interest that overwhelmingly supports Democrats like President Obama. Now, you have the opportunity to comment on this rule and tell the CFPB to stay out of your financial decisions.

The House is hitting the ground running with two important bills - H.R. 11 and 12 - The Lilly Ledbetter Fair Pay Act and the Paycheck Fairness Act.  You might think that as America sinks deeper in recession that Congress might try to avoid bills that are so blatantly harmful to business. But you would be pretty much completely wrong. Nancy Pelosi's House is less concerned with helping businesses thrive, than they are about giving some love to the trial lawyers. While everyone has been focusing on the growing "Economic Stimulus Package" H.R. 11 and H.R.